Synergistic Gastrointestinal Therapeutic Systems
Legal Citation
Summary of the Inventive Concept
A novel, integrated system combining implantable and non-invasive stimulators with AI, IoT, blockchain, and advanced materials for personalized, data-driven gastrointestinal therapeutics.
Background and Problem Solved
The original patent addressed gastrointestinal therapeutics through implantable and non-invasive stimulators. However, these systems lacked real-time data analysis, secure data storage, and personalized treatment planning. The new inventive concept integrates distinct technologies to create a more powerful, synergistic system that addresses these limitations.
Detailed Description of the Inventive Concept
The system comprises a miniaturized implant or non-invasive stimulator integrated with AI-powered diagnostic modules for real-time analysis of GI tract activities. IoT sensors enable real-time monitoring of patient physiological signals, while blockchain-based data storage ensures secure patient data management. The system also incorporates novel biocompatible materials, data analytics modules, and AI-driven predictive analytics for personalized treatment planning. The wearable device tracks gut-brain axis activities, and a mobile app enables patient engagement and data tracking.
Novelty and Inventive Step
The new claims introduce the integration of AI, IoT, blockchain, and advanced materials with implantable and non-invasive stimulators, providing a synergistic system that offers real-time data analysis, secure data storage, and personalized treatment planning. This integration is new and non-obvious compared to the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include varying the type of AI algorithm used, incorporating different IoT sensors, or utilizing alternative blockchain-based data storage solutions. Variations may also include integrating the system with other healthcare technologies, such as telemedicine platforms or electronic health records.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the gastrointestinal therapeutics market, with applications in treating gastrointestinal dysmotility, obesity, and other related disorders. The system's data-driven approach and personalized treatment planning capabilities position it for success in the growing digital health market.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering, specifically gastrointestinal stimulation technologies, focusing on electrical neurostimulation systems for therapeutic interventions
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device researcher with expertise in electrical stimulation, neural interface technologies, signal processing, and medical device integration, holding advanced degrees in bioengineering or related fields
Obviousness Rationale
A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies with existing electrical stimulation systems represents a predictable technological evolution. The source patent's foundational work on transcutaneous and implantable stimulators provides a clear technical framework for extending functionality through digital technologies. The proposed variations leverage known computational and communication technologies to enhance the core stimulation methodology described in the original patent.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,783 |
|---|---|
| Title | Implantable and non-invasive stimulators for gastrointestinal therapeutics |
| Assignee(s) | The Regents of the University of California |